PaySign Inc. (PAYS)
NASDAQ: PAYS
· Real-Time Price · USD
5.28
0.12 (2.33%)
At close: Sep 11, 2025, 10:18 AM
PaySign Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Revenue Revenue | 580.52K | 569.62K | 493.79K | 542.01K | 383.44K | 433.4K | 468.11K | 312.34K | 297.35K | 193.66K | 176.65K | 73.26K | 19.26K | 19.71K | 37.13K | 71.31K | 62.94K | 5.38M | 6.3M | 5.19M | 4.57M | 7.34M |
| Other Revenue Revenue Growth | +1.91% | +15.36% | -8.90% | +41.36% | -11.53% | -7.42% | +49.87% | +5.04% | +53.54% | +9.63% | +141.12% | +280.32% | -2.25% | -46.93% | -47.93% | +13.30% | -98.83% | -14.53% | +21.44% | +13.43% | -37.73% | n/a |
| Pharma Industry Revenue | 7.75M | 8.62M | 9.98M | 11.44M | 2.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pharma Industry Revenue Growth | -10.03% | -13.62% | -12.78% | +327.66% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Plasma Industry Revenue | 10.74M | 9.41M | 21.17M | n/a | 11.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Plasma Industry Revenue Growth | +14.18% | -55.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.2M | 7.4M | 7.03M | 6.22M | 6.02M | 5.91M | 5.33M | 4.7M | 5.3M | 4.95M | 4.42M | 4.39M | 4.26M | 4.64M | 4M | 3.62M | 3.47M | 3.86M | 3.79M | 4.07M | 3.4M | 3.83M | 3.17M | 2.77M | 3.01M | 2.7M | 2.59M | 2M | 1.67M | 1.58M | 1.21M | 1.1M | 928.59K | 814.28K | 854.17K | 794.42K | 808.28K | 831.5K | 877.45K | 1.27M | 786.8K | 907.87K |
| Selling, General, and Administrative Revenue Growth | +10.77% | +5.25% | +13.08% | +3.28% | +1.85% | +10.90% | +13.49% | -11.46% | +7.26% | +11.96% | +0.69% | +3.07% | -8.29% | +16.15% | +10.44% | +4.13% | -10.10% | +1.91% | -6.83% | +19.66% | -11.13% | +20.63% | +14.71% | -8.20% | +11.39% | +4.41% | +29.74% | +19.73% | +5.63% | +30.73% | +9.38% | +18.92% | +14.04% | -4.67% | +7.52% | -1.71% | -2.79% | -5.24% | -30.95% | +61.51% | -13.34% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |